<qa>  What is the name of the PHASE IIA?A PHASE IIA. OPEN-LABEL, MULTICENTER, DOSE-ESCALATION STUDY TO ASSESS THE TOLERABILITY AND PHARMACOKINETICS OF ZD4054 ZIBOTENTAN GIVEN ORALLY ONCE DAILY IN SUBJECTS WITH METASTATIC PROSTATE CANCER: 